If you liked this article you might like

Can This Pharma Stock Withstand the 'Trump Effect'?
Mylan Hit After Abbott Dumps Shares
Immunomedics, Mylan Lead Biotech Movers
Mylan's Government Connections Go Deeper Than Initially Reported